Bulent Aydogan to Survival Analysis
This is a "connection" page, showing publications Bulent Aydogan has written about Survival Analysis.
Connection Strength
0.028
-
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671.
Score: 0.028